The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2009

Gelijkaardige items

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma
door: Marta Cesca, et al.
Gepubliceerd in: (2009-11-01)

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
door: Edmond Auzenne, et al.
Gepubliceerd in: (2007-06-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
door: Wachsberger, P, et al.
Gepubliceerd in: (2009)

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
door: Lavinia Morosi, et al.
Gepubliceerd in: (2013-01-01)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
door: Choi, S, et al.
Gepubliceerd in: (2008)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
door: Demuytere J, et al.
Gepubliceerd in: (2024-01-01)

Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
door: Martina Vescio, et al.
Gepubliceerd in: (2023-07-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
door: Hideki Iwamoto, et al.
Gepubliceerd in: (2011-03-01)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
door: Cervellini, I, et al.
Gepubliceerd in: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
door: Tai, J, et al.
Gepubliceerd in: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
door: Tai, J, et al.
Gepubliceerd in: (2010)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
door: Nils Degrauwe, et al.
Gepubliceerd in: (2012-06-01)

Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer
door: Xiao W, et al.
Gepubliceerd in: (2012-03-01)

Selective use of vandetanib in the treatment of thyroid cancer
door: Fallahi P, et al.
Gepubliceerd in: (2015-07-01)

PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
door: Lavinia Morosi, et al.
Gepubliceerd in: (2021-09-01)

Assessment of Acute Antivascular Effects of Vandetanib with High-Resolution Dynamic Contrast-Enhanced Computed Tomographic Imaging in a Human Colon Tumor Xenograft Model in the Nude Rat
door: Joo Ho Tai, et al.
Gepubliceerd in: (2010-09-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
door: Kabir, Md Zahirul, et al.
Gepubliceerd in: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
door: Abdul Qadir, MPhil, et al.
Gepubliceerd in: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
door: Jade Cury-Martins, et al.
Gepubliceerd in: (2018-10-01)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
door: Roberta Affatato, et al.
Gepubliceerd in: (2022-05-01)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
door: Zhou, J, et al.
Gepubliceerd in: (2016)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
door: Alferez, D, et al.
Gepubliceerd in: (2010)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
door: Francesca Ricci, et al.
Gepubliceerd in: (2017-05-01)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
door: Heymach, J, et al.
Gepubliceerd in: (2008)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
door: Siemann, D, et al.
Gepubliceerd in: (2009)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
door: Yuxin Shen, et al.
Gepubliceerd in: (2025-03-01)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
door: Hari Deshpande, et al.
Gepubliceerd in: (2011-01-01)

Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer
door: Dong Choon Park, et al.
Gepubliceerd in: (2008-09-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
door: Ai Matsui, et al.
Gepubliceerd in: (2022-01-01)

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
door: Joseph J. Caumanns, et al.
Gepubliceerd in: (2025-02-01)

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
door: Paola De Feudis, et al.
Gepubliceerd in: (2000-05-01)

Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
door: Robert J G Cardnell, et al.
Gepubliceerd in: (2011-01-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
door: Fallahi P, et al.
Gepubliceerd in: (2019-08-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
door: T. Laragione, et al.
Gepubliceerd in: (2005-01-01)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
door: Busra Demirbag Gul, et al.
Gepubliceerd in: (2022-02-01)

LAMININ-5. A POTENTIAL TOOL IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
door: Hartwig Kosmehl, et al.
Gepubliceerd in: (2002-12-01)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
door: E. A. Samishina, et al.
Gepubliceerd in: (2019-06-01)

Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel
door: Pepe D, et al.
Gepubliceerd in: (2016-05-01)

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
door: Jr, W, et al.
Gepubliceerd in: (2012)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
door: Carlos M. Galmarini, et al.
Gepubliceerd in: (2014-01-01)